insulin administration
Showing 1 - 25 of >10,000
Closed-loop Hybrid Insulin Administration During Ramadan Fasting
Not yet recruiting
- Type1diabetes
- closed-loop hybrid insulin administration
-
Corbeil-essonnes Cedex, FranceCentre Hospitalier Sud Francilien
Feb 17, 2023
Education, Patient Trial in Izmir (Video-assisted training)
Active, not recruiting
- Education, Patient
- Video-assisted training
-
İzmir, Menemen, Turkeyizmir Bakircay University
Jun 21, 2023
Type 1 Diabetes, Hyperglycemia, Postprandial Trial in Saint Louis (Insulin)
Terminated
- Type 1 Diabetes
- Hyperglycemia, Postprandial
-
Saint Louis, MissouriWashington University in St Louis
Sep 13, 2022
Diabetic Ketoacidosis, Type 1 Diabetes, Type 2 Diabetes Trial in Cleveland (Early Glargine, Late Glargine, IV insulin infusion)
Terminated
- Diabetic Ketoacidosis
- +2 more
- Early Glargine
- +3 more
-
Cleveland, OhioCleveland Clinic Fairview Hospital
Aug 1, 2022
Diabetes, Hyperglycemia Trial (Best Practice Advisory)
Not yet recruiting
- Diabetes
- Hyperglycemia
- Best Practice Advisory
- (no location specified)
Aug 16, 2022
Diabetes, Type 2, Insulin Injection Pad, Injection Site Trial in Kadiköy (Video group)
Completed
- Diabetes Mellitus, Type 2
- +4 more
- Video group
-
Kadıköy, İstanbul, TurkeyGoztepe Prof Dr Suleyman Yalcın City Hospital
Dec 13, 2022
DKA Trial in Saint Paul (Insulin Glargine)
Recruiting
- DKA
- Insulin Glargine
-
Saint Paul, MinnesotaRegions Hospital
Aug 21, 2023
Insulin Sensitivity Trial in Tuebingen (intranasal insulin, Placebo spray)
Completed
- Insulin Sensitivity
- intranasal insulin
- Placebo spray
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Sep 2, 2021
Diabetes, Type 1, Children, Metabolic Control Trial in Hasselt (Questionnaire)
Completed
- Diabetes Mellitus, Type 1
- +3 more
- Questionnaire
-
Hasselt, Limburg, BelgiumJessa Hospital
Sep 22, 2022
Metabolic Syndrome Trial in Guadalajara (Celery Seed, Placebo)
Recruiting
- Metabolic Syndrome
- Celery Seed
- Placebo
-
Guadalajara, Jalisco, MexicoINSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universi
Sep 25, 2023
PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia Trial in Guadalajara (Probiotics, Metformin)
Active, not recruiting
- PreDiabetes
- +3 more
- Probiotics
- Metformin
-
Guadalajara, Jalisco, MexicoINSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universi
Jan 8, 2023
Insulin Dependent Diabetes, Diabetes type2 Trial in Sirnak
Completed
- Insulin Dependent Diabetes
- Diabetes type2
-
Şirnak, Merkez, TurkeyŞirnak Devlet Hastanesi
Jun 22, 2023
Delirium, Heart Diseases Trial in Montreal (Regular Insulin, Human 100 UNT/ML, Normal Saline Flush, 0.9% Injectable Solution)
Not yet recruiting
- Delirium
- Heart Diseases
- Regular Insulin, Human 100 UNT/ML
- Normal Saline Flush, 0.9% Injectable Solution
-
Montreal, Quebec, CanadaRoyal Victoria Hospital McGill University Health Centre
Oct 13, 2021
Insulin Resistance, Colorectal Cancer Trial (BCAA, water)
Not yet recruiting
- Insulin Resistance
- Colorectal Cancer
- BCAA
- water
- (no location specified)
Aug 12, 2022
Diabetes, Type 2 Trial in Mainz (Insulin icodec)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
-
Mainz, GermanyNovo Nordisk Investigational Site
Jan 19, 2023
Diabetes, Cardiac Event Trial in Amman (Fast-acting human insulin)
Completed
- Diabetes Mellitus
- Cardiac Event
- Fast-acting human insulin
-
Amman, JordanPrince Hamza Hospital
Mar 27, 2021
Prediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance Trial in Guadalajara (Berberine, Metformin)
Active, not recruiting
- Prediabetes
- +2 more
- Berberine
- Metformin
-
Guadalajara, Jalisco, MexicoInstituto de Terapeútica Experimental y Clínica. Centro Universi
Jun 2, 2022
Insulin Resistance, Diabetes Trial in Montreal (Maltodextrin solution, Water solution)
Not yet recruiting
- Insulin Resistance
- Diabetes Mellitus
- Maltodextrin solution
- Water solution
-
Montreal, Quebec, CanadaJewish General Hospital
May 2, 2022
Cognitive Decline, Heart Diseases, Delirium Trial (Regular insulin, Normal Saline Flush, 0.9% Injectable Solution)
Not yet recruiting
- Cognitive Decline
- +2 more
- Regular insulin
- Normal Saline Flush, 0.9% Injectable Solution
- (no location specified)
Jan 25, 2021
Pancretic Cancer, Diabete Mellitus Trial (Metformin or insulin treatment)
Not yet recruiting
- Pancretic Cancer
- Diabete Mellitus
- Metformin or insulin treatment
- (no location specified)
Mar 23, 2022
Type 1 Diabetes Trial in New Haven (Insulin Degludec, Insulin Glargine)
Completed
- Type 1 Diabetes Mellitus
- Insulin Degludec
- Insulin Glargine
-
New Haven, ConnecticutYale University
Nov 4, 2021
Diabetic Ketoacidosis Trial in Baltimore (Early administration of subcutaneous insulin glargine dose, IV insulin infusion, IV
Completed
- Diabetic Ketoacidosis
- Early administration of subcutaneous insulin glargine dose
- +2 more
-
Baltimore, MarylandUniversity of Maryland Medical Center
Mar 19, 2022
Anorexia Nervosa Trial in Boston (RhIGF-1)
Completed
- Anorexia Nervosa
-
Boston, MassachusettsMassachusetts General Hospital
Oct 22, 2021